UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                             -----------------------


                                    FORM 8-K


                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported): October 10, 2002

                             -----------------------


                            KINDRED HEALTHCARE, INC.
             (Exact name of registrant as specified in its charter)


              Delaware                    001-14057            61-1323993
   (State or other jurisdiction       (Commission File        (IRS Employer
 of incorporation or organization)         Number)          Identification No.)


                             680 South Fourth Street
                              Louisville, Kentucky
                    (Address of principal executive offices)
                                   40202-2412
                                   (Zip Code)

       Registrant's telephone number, including area code: (502) 596-7300

                                 Not Applicable
         (Former name or former address, if changed since last report.)



Item 5.  Other Events and Regulation FD Disclosure.

         Kindred Healthcare, Inc. ("Company") has announced that that it will
record approximately $55 million of additional costs for professional liability
claims above its normal provision for the third quarter ended September 30,
2002. The additional claims costs are required based upon the results of a
recently completed regular quarterly independent actuarial valuation.
Substantially all of the additional claims costs relate to the Company's nursing
center operations.

         The Company stated that these changes in estimate relate primarily to
claims incurred in fiscal 2001 and 2002. The portion of the adjustment relating
to a change in estimate for claims incurred in fiscal 2001 will approximate $25
million, while $30 million of the adjustment relates to a revision of the fiscal
2002 estimated cost for the nine months ended September 30, 2002. Claims cost
estimates for years prior to fiscal 2001 remained relatively unchanged.

         The Company noted that the latest actuarial valuation indicated that
substantially all of the cost increase for 2001 related to an increase in the
average expected cost per claim. The actuarial valuation also indicated that the
total number of expected claims that ultimately will be incurred in 2001
remained relatively unchanged from the previous valuation completed for the
second quarter of this year. The actuarial cost estimate for the 2002 liability
claims cost has been increased based upon the revised 2001 cost trend. In
addition, approximately two-thirds of the adjustments for 2001 and 2002 related
to the Company's operations in Florida.

         Based upon the actuarial valuation, the Company intends to accrue an
additional $10 million of professional liability claims cost above its normal
provision for the fourth quarter of 2002. The regular quarterly independent
actuarial valuation will be performed at the end of the year.

         In light of the dramatic increase in professional liability costs in
Florida, the Company is aggressively pursuing alternatives to reduce its
exposure, including divesting its nursing center operations in Florida. The
Company has contacted Ventas, Inc. ("Ventas"), its primary landlord, to discuss
the Company's strategic alternatives regarding its Florida operations. The
Company operates 18 nursing centers in Florida, of which 15 are leased from
Ventas.

         As previously disclosed in its Annual Report on Form 10-K, the Company
insures a substantial portion of its professional liability risks through a
wholly owned limited purpose insurance subsidiary, Cornerstone Insurance Company
("Cornerstone"). Coverage for losses in excess of those insured by Cornerstone
are maintained through unaffiliated commercial insurance carriers. Aggregate
professional liability costs were $34.3 million for the six months ended June
30, 2002 and $27.8 million for the six months ended June 30, 2001. For the year
ended December 31, 2001, aggregate professional liability costs were $65.8
million.

         Provisions for loss for professional liability risks retained by
Cornerstone are discounted based upon management's estimate of long-term
investment yields and independent actuarial estimates of claim payment patterns.
The interest rate used to discount funded professional liability risks is 5%.
Amounts equal to the discounted loss provision are funded annually. The Company
does not fund the portion of professional liability risks related to estimated
claims that

                                       2



have been incurred but not reported. Accordingly, these liabilities are not
discounted. Assets related to professional liability claims approximated $125.9
million at June 30, 2002 and $105.0 million at December 31, 2001. Reserves for
professional liability risks were $176.6 million at June 30, 2002 and $163.3
million at December 31, 2001.

         Based upon the actuarial valuation, the Company expects to fund
approximately $45 million of the previously discussed adjustments into
Cornerstone no later than the first quarter of 2003. The Company believes that
its current and expected cash levels will be adequate to fund its professional
liability obligations for 2002. The Company also expects to be in compliance
with the financial covenants under its revolving credit facility and senior
secured notes agreement at September 30, 2002.

         The Company also stated that certain additional adjustments may be
recorded in connection with asset valuations in the third quarter, including a
write-down of the value of its nursing center operations in Florida. The Company
also is reviewing the expected recoverability of recorded amounts of goodwill
and may record a third quarter charge based on the results of the review.

Outlook Update

         The Company intends to revise its earnings guidance for fiscal 2002 at
the time of its third quarter earnings release and is withdrawing its previously
issued earnings guidance at this time.

         This Form 8-K includes forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act, as amended. All statements regarding the Company's
expected future financial position, results of operations, cash flows, financing
plans, business strategy, budgets, capital expenditures, competitive positions,
growth opportunities, plans and objectives of management and statements
containing the words such as "anticipate," "approximate," "believe," "plan,"
"estimate," "expect," "projected," "could," "should," "will," "intend," "may"
and other similar expressions, are forward-looking statements.

         Such forward-looking statements are inherently uncertain, and
stockholders and other potential investors must recognize that actual results
may differ materially from the Company's expectations as a result of a variety
of factors, including, without limitation, those discussed below. Such
forward-looking statements are based on management's current expectations and
include known and unknown risks, uncertainties and other factors, many of which
the Company is unable to predict or control, that may cause the Company's actual
results or performance to differ materially from any future results or
performance expressed or implied by such forward-looking statements. These
statements involve risks, uncertainties and other factors detailed from time to
time in the Company's filings with the Securities and Exchange Commission.

         Factors that may affect the Company's plans or results include, without
limitation, (a) the Company's ability to operate pursuant to the terms of its
debt obligations and its master lease agreements with Ventas; (b) the Company's
ability to meet its rental and debt service obligations; (c) adverse
developments with respect to the Company's liquidity or results of operations;
(d) the Company's ability to attract and retain key executives and other
healthcare

                                       3



personnel; (e) increased operating costs due to shortages in qualified nurses
and other healthcare professionals; (f) the effects of healthcare reform and
government regulations, interpretation of regulations and changes in the nature
and enforcement of regulations governing the healthcare industry; (g) changes in
the reimbursement rates or methods of payment from third-party payors, including
the Medicare and Medicaid programs and the new prospective payment system for
long-term acute care hospitals; (h) national and regional economic conditions,
including their effect on the availability and cost of labor, materials and
other services; (i) the Company's ability to control costs including labor and
employee benefit costs, in response to the prospective payment systems,
implementation of the Company's Corporate Integrity Agreement and other
regulatory actions; (j) the Company's ability to comply with the terms of its
Corporate Integrity Agreement; (k) the effect of a restatement of the Company's
previously issued consolidated financial statements; (l) the Company's ability
to integrate operations of acquired facilities; and (m) the increase in the
costs of defending and insuring against alleged patient care liability claims
and the Company's ability to predict the estimated costs related to such claims.
Many of these factors are beyond the control of the Company and its management.
The Company cautions investors that any forward-looking statements made by the
Company are not guarantees of future performance. The Company disclaims any
obligation to update any such factors or to announce publicly the results of any
revisions to any of the forward-looking statements to reflect future events or
developments.

         A copy of the press release issued by the Company is attached as
Exhibit 99.1

Item 7.  Financial Statements and Exhibits.

         (a)   Financial statements of businesses acquired.

               Not applicable.

         (b)   Pro forma financial information.

               Not applicable.

         (c)   Exhibits.

               Exhibit 99.1 - Press Release dated October 10, 2002.

                                       4



                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereto duly authorized.

                                   KINDRED HEALTHCARE, INC.


Date: October 11, 2002             By: /s/ Richard A. Lechleiter
                                       --------------------------------------
                                          Richard A. Lechleiter
                                          Senior Vice President, Chief Financial
                                          Officer and Treasurer

                                       5